Is fibrinogen concentrate useful for bleeding in high-risk cardiac surgery? In a study conducted in The Netherlands, [1] 647 patients (from 2011 to 2015) scheduled to have high-risk cardiac surgery ...

The top panel, designed with BioRender.com, illustrates the process of clot formation and lysis, beginning with platelet aggregation and activation of the coagulation cascade, followed by the ...

Fibryga was found to be noninferior to cryoprecipitate based on the total number of units of allogeneic blood products administered during the first 24 hours after termination of cardiopulmonary ...

Fesilty is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Fesilty ™ (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in ...